Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20220516054879N6Phase 3Completed
Phase 3, double-blind trial of hypericum perforatum and dexpanthenol in surgical scar (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: SCAR scale total and component assessment, Scar spread and 7 more. Started Jun 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20220516054879N6.